Please login to the form below

Not currently logged in
Email:
Password:

EULAR

This page shows the latest EULAR news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s upadacitinib tops Humira again in arthritis trial

AbbVie’s upadacitinib tops Humira again in arthritis trial

The results – presented at the EULAR congress in Madrid this week – are another boost to AbbVie’s hopes of positive verdicts from the FDA and EMA when their reviews of the

Latest news

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Case study: Immunology education Case study: Immunology education

    Sue Oliver, chair of the European League Against Rheumatism (EULAR) Healthcare Professionals Standing Committee said: “My personal experience as Arena Chair was a rewarding and exciting one.

  • Achieving remission Achieving remission

    Close collaboration with investor relations increased interest beyond medical media. •   ‘Realising the goal of remission’ media briefing held at EULAR 2009.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics